Sector Gamma As as of Dec. 31, 2018
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 33 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | 10.9 | $65M | 897k | 72.33 | |
| Bristol Myers Squibb (BMY) | 9.9 | $59M | 1.1M | 51.98 | |
| Boston Scientific Corporation (BSX) | 7.8 | $46M | 1.3M | 35.34 | |
| Merck & Co (MRK) | 5.9 | $35M | 461k | 76.41 | |
| Baxter International (BAX) | 5.4 | $32M | 490k | 65.82 | |
| PerkinElmer (RVTY) | 4.7 | $28M | 359k | 78.55 | |
| Gilead Sciences (GILD) | 4.6 | $27M | 434k | 62.55 | |
| NuVasive | 4.0 | $24M | 474k | 49.56 | |
| Bio-Rad Laboratories (BIO) | 3.8 | $23M | 97k | 232.22 | |
| Shire | 3.7 | $22M | 126k | 174.04 | |
| Incyte Corporation (INCY) | 3.6 | $21M | 336k | 63.59 | |
| Agilent Technologies Inc C ommon (A) | 3.6 | $21M | 315k | 67.46 | |
| Ionis Pharmaceuticals (IONS) | 3.5 | $21M | 379k | 54.06 | |
| Anthem (ELV) | 3.2 | $19M | 74k | 262.63 | |
| CVS Caremark Corporation (CVS) | 2.9 | $18M | 267k | 65.52 | |
| Celgene Corporation | 2.8 | $17M | 263k | 64.09 | |
| Qiagen Nv | 2.4 | $14M | 407k | 34.45 | |
| Perrigo Company (PRGO) | 2.0 | $12M | 307k | 38.75 | |
| Biogen Idec (BIIB) | 1.7 | $10M | 33k | 300.91 | |
| Patterson Companies (PDCO) | 1.6 | $9.5M | 482k | 19.66 | |
| Allergan | 1.6 | $9.4M | 70k | 133.66 | |
| Cardinal Health (CAH) | 1.6 | $9.2M | 206k | 44.60 | |
| Universal Health Services (UHS) | 1.5 | $9.1M | 78k | 116.56 | |
| Dr. Reddy's Laboratories (RDY) | 1.1 | $6.5M | 171k | 37.70 | |
| McKesson Corporation (MCK) | 1.1 | $6.2M | 57k | 110.48 | |
| Clovis Oncology | 1.0 | $6.0M | 336k | 17.96 | |
| Lexicon Pharmaceuticals (LXRX) | 1.0 | $5.7M | 863k | 6.64 | |
| Portola Pharmaceuticals | 0.9 | $5.6M | 285k | 19.52 | |
| Tenet Healthcare Corporation (THC) | 0.8 | $4.6M | 268k | 17.14 | |
| Alnylam Pharmaceuticals (ALNY) | 0.7 | $4.3M | 59k | 72.92 | |
| Array BioPharma | 0.6 | $3.4M | 241k | 14.25 | |
| Sangamo Biosciences (SGMO) | 0.3 | $1.8M | 155k | 11.48 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $348k | 8.0k | 43.50 |
